Vaccinex
VCNX
$0.80
Share price
-21.05%
Change (1 day)
-91.21%
Change (1 year)
Categories
Operating Margin for Vaccinex (VCNX)
Operating Margin as of April 2025 (TTM): -4,937.25%
According to Vaccinex's latest financial reports and stock price the company's current Operating Margin is -4,937.25%. At the end of 2023 the company had an Operating Margin of -3,552.81%.
Operating Margin history for Vaccinex from 2018 to 2024
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2023 | -3,552.81% | -50.69% |
| 2022 | -7,205.45% | 189.76% |
| 2021 | -2,486.67% | -95.69% |
| 2020 | -57,702.00% | 847.12% |
| 2019 | -6,092.35% | 49.43% |
| 2018 | -4,077.07% | -80.44% |
| 2017 | -20,843.33% | 372.39% |
| 2016 | -4,412.34% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 | 0.00% | N/A | 🇺🇸 USA |
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.